{"i": ["vilazodone", "vilazodone - treated", "placebo or vilazodone", "placebo - controlled", "placebo", "Vilazodone", "citalopram ( Celexa and others ), vilazodone ( Viibryd ).", "placebo .", "placebo -", "Placebo"], "o": ["apparent sadness", "depressive symptom improvement and anxious depression", "symptom improvement", "symptoms of depression and anxious depression", "psychic anxiety , somatic anxiety , gastrointestinal somatic symptoms , general somatic symptoms , hypochondriasis , and insight .", "depression symptoms", "threshold for no anxious depression ( HDRS - 17 anxiety / somatization", "category shift improvements", "anxious depression to no anxious depression .", "withdrawal of consent", "anxious depression", "sexual function", "symptom severity", "suicidality", "MADRS total score .", "pessimistic thoughts", "severe symptom ratings .", "Depressed mood , sleep disturbances , and fatigue", "reported sadness", "depressive symptoms", "reduced appetite", "depressive symptom severity category", "MADRS items of apparent sadness , reported sadness , inner tension , reduced sleep , and lassitude", "Depression symptom improvement", "suicidal thoughts", "severity category shift", "appetite", "depressive symptoms .", "discontinued prematurely", "inner tension item", "anxious depression to no anxious depression", "reduced sleep", "no anxious depression", "diarrhea , nausea , and insomnia .", "suicidal thoughts item", "inability to feel", "mean MADRS score", "symptomatic depression or anxious depression", "lassitude", "Montgomery - Asberg Depression Rating Scale ( MADRS", "MADRS suicidal thoughts", "HDRS - 17 anxiety / somatization score", "HDRS - 17 anxiety / somatization subscale", "adverse events", "concentration difficulties"]}